1	The	the	_	_	_	_	_	_	_
2	NF-kappa	NF-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	inhibitor	inhibitor	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	tepoxalin	tepoxalin	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	suppresses	suppress	_	_	_	_	_	_	_
9	surface	surface	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	adhesion	adhesion	_	_	_	_	_	_	_
15	molecules	molecule	_	_	_	_	_	_	_
16	CD62E	CD62E	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	CD11b/CD18	cd11b/cd18	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	CD106	CD106	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Tepoxalin	Tepoxalin	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	dual	dual	_	_	_	_	_	_	_
5	enzyme	enzyme	_	_	_	_	_	_	_
6	inhibitor	inhibitor	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	cyclooxygenase	cyclooxygenase	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	5-lipoxygenase	5-lipoxygenase	_	_	_	_	_	_	_
11	has	have	_	_	_	_	_	_	_
12	been	be	_	_	_	_	_	_	_
13	shown	show	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	inhibit	inhibit	_	_	_	_	_	_	_
16	T-cell	t-cell	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Its	its	_	_	_	_	_	_	_
2	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
3	property	property	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	distinct	distinct	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	cyclosporin	cyclosporin	_	_	_	_	_	_	_
8	because	because	_	_	_	_	_	_	_
9	only	only	_	_	_	_	_	_	_
10	tepoxalin	tepoxalin	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	but	but	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	cyclosporin	cyclosporin	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	suppresses	suppress	_	_	_	_	_	_	_
17	NF-kappa	NF-kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	tepoxalin	tepoxalin	_	_	_	_	_	_	_
6	selectively	selectively	_	_	_	_	_	_	_
7	inhibits	inhibit	_	_	_	_	_	_	_
8	intercellular	intercellular	_	_	_	_	_	_	_
9	adhesion	adhesion	_	_	_	_	_	_	_
10	molecule-1	molecule-1	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	ICAM-1	ICAM-1	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	CD54)/MAC-1	CD54)/MAC-1	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	CD11b/CD18	cd11b/cd18	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	dependent	dependent	_	_	_	_	_	_	_
19	adhesion	adhesion	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	polymorphonuclear	polymorphonuclear	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	IL-1	il-1	_	_	_	_	_	_	_
25	activated	activate	_	_	_	_	_	_	_
26	human	human	_	_	_	_	_	_	_
27	umbilical	umbilical	_	_	_	_	_	_	_
28	vein	vein	_	_	_	_	_	_	_
29	endothelial	endothelial	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	mechanism	mechanism	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	inhibition	inhibition	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	related	related	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	surface	surface	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	several	several	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	adhesion	adhesion	_	_	_	_	_	_	_
15	molecules	molecule	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Flow	Flow	_	_	_	_	_	_	_
2	cytometry	cytometry	_	_	_	_	_	_	_
3	analyses	analysis	_	_	_	_	_	_	_
4	on	on	_	_	_	_	_	_	_
5	cultured	culture	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	treated	treat	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	tepoxalin	tepoxalin	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	antisense	antisense	_	_	_	_	_	_	_
14	oligonucleotides	oligonucleotide	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	P65/p50	p65/p50	_	_	_	_	_	_	_
18	subunit	subunit	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	then	then	_	_	_	_	_	_	_
25	stimulated	stimulate	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	PMA	PMA	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	revealed	reveal	_	_	_	_	_	_	_
30	a	a	_	_	_	_	_	_	_
31	reduced	reduce	_	_	_	_	_	_	_
32	expression	expression	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	CD11b/CD18	cd11b/cd18	_	_	_	_	_	_	_
35	on	on	_	_	_	_	_	_	_
36	monocytic	monocytic	_	_	_	_	_	_	_
37	HL60	hl60	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	endothelial	endothelial	_	_	_	_	_	_	_
42	adhesion	adhesion	_	_	_	_	_	_	_
43	molecule-1	molecule-1	_	_	_	_	_	_	_
44	(	(	_	_	_	_	_	_	_
45	CD62E	CD62E	_	_	_	_	_	_	_
46	)	)	_	_	_	_	_	_	_
47	and	and	_	_	_	_	_	_	_
48	vascular	vascular	_	_	_	_	_	_	_
49	adhesion	adhesion	_	_	_	_	_	_	_
50	molecule-1	molecule-1	_	_	_	_	_	_	_
51	(	(	_	_	_	_	_	_	_
52	CD106	CD106	_	_	_	_	_	_	_
53	)	)	_	_	_	_	_	_	_
54	on	on	_	_	_	_	_	_	_
55	human	human	_	_	_	_	_	_	_
56	umbilical	umbilical	_	_	_	_	_	_	_
57	vein	vein	_	_	_	_	_	_	_
58	endothelial	endothelial	_	_	_	_	_	_	_
59	cells	cell	_	_	_	_	_	_	_
60	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	adhesion	adhesion	_	_	_	_	_	_	_
5	molecules	molecule	_	_	_	_	_	_	_
6	such	such	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	lymphocyte	lymphocyte	_	_	_	_	_	_	_
9	function	function	_	_	_	_	_	_	_
10	associated-antigen-1	associated-antigen-1	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	CD11a/CD18	cd11a/cd18	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	CD54	CD54	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	unaffected	unaffected	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Tepoxalin	Tepoxalin	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	inhibited	inhibit	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	secretion	secretion	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	NF-kappa	NF-kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	regulated	regulated	_	_	_	_	_	_	_
11	chemokine	chemokine	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	IL-8	IL-8	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	known	known	_	_	_	_	_	_	_
17	inducer	inducer	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	CD11b/CD18	cd11b/cd18	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	suppression	suppression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	CD11b/CD18	cd11b/cd18	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	tepoxalin	tepoxalin	_	_	_	_	_	_	_
9	may	may	_	_	_	_	_	_	_
10	involve	involve	_	_	_	_	_	_	_
11	IL-8	il-8	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	inhibiting	inhibit	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	surface	surface	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	several	several	_	_	_	_	_	_	_
15	adhesion	adhesion	_	_	_	_	_	_	_
16	molecules	molecule	_	_	_	_	_	_	_
17	can	can	_	_	_	_	_	_	_
18	be	be	_	_	_	_	_	_	_
19	modulated	modulate	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	tepoxalin	tepoxalin	_	_	_	_	_	_	_
23	may	may	_	_	_	_	_	_	_
24	be	be	_	_	_	_	_	_	_
25	useful	useful	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	treating	treat	_	_	_	_	_	_	_
28	selected	select	_	_	_	_	_	_	_
29	adhesion	adhesion	_	_	_	_	_	_	_
30	mediated	mediated	_	_	_	_	_	_	_
31	events	event	_	_	_	_	_	_	_
32	such	such	_	_	_	_	_	_	_
33	as	as	_	_	_	_	_	_	_
34	leukocyte	leukocyte	_	_	_	_	_	_	_
35	migration	migration	_	_	_	_	_	_	_
36	or	or	_	_	_	_	_	_	_
37	atherosclerotic	atherosclerotic	_	_	_	_	_	_	_
38	plaque	plaque	_	_	_	_	_	_	_
39	formation	formation	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

